Arca Biopharma Stock Predictions

Healthcare > Biotechnology

Buy ABIO

*Your capital is at risk

$2.40

+0 (+0%)

At Close: Nov 29, 2024

Currently predicting for Fri, 17 Jul 2026

ABIO Live board

Community Bull/Bear

Target Next close

Join the ABIO prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

ABIO Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For ABIO

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

ABIO Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT ARCA BIOPHARMA

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
DHT $17.31	4.04%	Jul 13
SRPT $17.02	3.47%	Jun 29
NMRK $15.02	3.26%	Jun 24
JLL $299.78	9.38%	Jun 24
NESR $25.07	15.24%	Jun 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by